Specific and nonspecific rashes associated with antibodies to Ro/SS-A are often related to subacute cutaneous lupus erythematosus (SCLE). Typically, lesions specific to SCLE do not itch and may ...

PF-06823859 is a potent, selective, humanised immunoglobulin 1-neutralising monoclonal antibody (mAb) directed against human ...

Patient 4: Anifrolumab effectively managed refractory subacute cutaneous lupus erythematosus, resulting in remarkable cutaneous improvement and successful tapering of prednisone and mycophenolate ...

The Subacute Cutaneous Lupus Erythematosus (SCLE) drugs in development market research report provides comprehensive information on the therapeutics under development for Subacute Cutaneous Lupus ...

overview Chronic Cutaneous Lupus Erythematosus also known as discoid lupus is a group of autoimmune disorders affecting the major areas of skin that can be associated with SLE. CLE is classified as ...

The most common clinical subtype of cutaneous lupus among concordance cases was subacute cutaneous lupus erythematosus, and this was found in 18 patients. Skin biopsies are infrequently performed in ...

Systemic Lupus Erythematosus (SLE): Around 70% of people with lupus ... In fact, there are actually three subtypes: chronic cutaneous (discoid) lupus, subacute cutaneous lupus, and acute cutaneous ...

In 12 patients with underlying cardiac disease subacute streptococcal endocarditis ... Two patients had advanced systemic lupus erythematosus, and 1 had undergone dialysis for the treatment ...

Having lupus may increase your risk of food allergies. And certain foods may trigger lupus flares. Learn more.

Systemic lupus can be mild or severe. Cutaneous lupus erythematosus This form of lupus is limited to the skin and can cause many types of rashes and lesions. Drug-induced lupus erythematosus This is a ...

Immune cells called monocytes produce a key inflammatory protein called interleukin-1 beta (IL-1β) through an unconventional ...

There are no significant differences in outcomes post-AMI in patients with systemic lupus erythematosus vs the general population.